The UK Department of Health and Social Care's aid-funded global health research and innovation

This review concludes that UK aid contributes positively to global health with results such as the Oxford COVID-19 vaccine, but that more focus on achieving impact is needed.

13.04.26

Independent Commission for Aid Impact

Independent Commission for Aid Impact

2024

Read the review
Share

This review concludes that UK aid contributes positively to global health with results such as the Oxford COVID-19 vaccine, but that more focus on achieving impact is needed.

Findings

  • Global health research and innovation funded by the Department of Health and Social Care is largely relevant to the issues faced by poor people in low- and middle-income countries
  • We also found it effective, with successes such as the Oxford Covid-19 vaccine, a welcome focus to underfunded areas such as mental health and pioneering community engagement in many cases.
  • DHSC’s programming aligns well with UK government strategies related to global health research, which prioritise economic and trade objectives alongside resilience to health threats such as pandemics.
  • However, DHSC does not always focus on research which could drive the greatest impact, such as evidence synthesis.
  • Transparency about programmes funded is patchy and reporting of results to ensure accountability for research impact is weak, considering the scale of the department’s official development assistance (ODA) spending.
  • If DHSC’s aid is to be most effective, it needs to be ‘untied’, allowing researchers in low and middle-income countries to choose partners from anywhere in the world, not just the UK.